Aricept Related Published Studies
Well-designed clinical trials related to Aricept (Donepezil)
The effect of a combination of gabapentin and donepezil in an experimental pain
model in healthy volunteers: Results of a randomized controlled trial. [2014]
Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for
the treatment of Alzheimer's disease: a systematic review and meta-analysis. [2014]
Evaluation of an 8-item Severe Impairment Battery (SIB-8) vs. the full SIB in
moderate to severe Alzheimer's disease patients participating in a donepezil
study. [2013]
Ventricular enlargement and its clinical correlates in the imaging cohort from
the ADCS MCI donepezil/vitamin E study. [2013]
Donepezil and memantine for moderate-to-severe Alzheimer's disease. [2012]
Pilot randomized trial of donepezil hydrochloride for delirium after hip fracture. [2011.11]
Combination treatment in Alzheimer's disease: results of a randomized, controlled trial with cerebrolysin and donepezil. [2011.08]
Enhancing recovery after acute ischemic stroke with donepezil as an adjuvant therapy to standard medical care: results of a phase IIA clinical trial. [2011.05]
SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study. [2011.05]
Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis. [2011.04.26]
Safety and efficacy of donepezil in children and adolescents with autism: neuropsychological measures. [2011.02]
Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease. [2011.02]
Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy. [2011.01]
Donepezil treatment in Alzheimer's disease patients with and without cerebrovascular lesions: a preliminary report. [2011.01]
Donepezil significantly improves abilities in daily lives of female Down syndrome patients with severe cognitive impairment: a 24-week randomized, double-blind, placebo-controlled trial. [2011]
A double-blind placebo-controlled randomized trial of Melissa officinalis oil and donepezil for the treatment of agitation in Alzheimer's disease. [2011]
Pilot randomized trial of donepezil hydrochloride for delirium after hip
fracture. [2011]
An MRI substudy of a donepezil clinical trial in mild cognitive impairment. [2011]
Donepezil for treatment of cognitive dysfunction in children with Down syndrome aged 10-17. [2010.12]
SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study. [2010.09.24]
Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study. [2010.07]
Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size. [2010.06]
Safety and tolerability of donepezil in mild cognitive impairment: open-label extension study. [2010.03]
Memantine versus donepezil in mild to moderate Alzheimer's disease: a randomized trial with magnetic resonance spectroscopy. [2010.03]
The long-term efficacy and tolerability of donepezil in patients with vascular dementia. [2010.03]
Donepezil treatment and the subjective effects of intravenous cocaine in dependent individuals. [2010.02.01]
Bioequivalence study of two different tablet formulations of donepezil using truncated areas under the curve. A single-center, single-dose, randomized, open-label, 2-way crossover study under fasting conditions. [2010]
Effect of donepezil on cognition in severe Alzheimer's disease: a pooled data analysis. [2010]
Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10
mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized,
double-blind study. [2010]
Effects of donepezil on activities of daily living: integrated analysis of
patient data from studies in mild, moderate and severe Alzheimer's disease. [2010]
Rates of cognitive change in Alzheimer disease: observations across a decade of placebo-controlled clinical trials with donepezil. [2009.10]
The effects of counseling spouse caregivers of people with Alzheimer disease taking donepezil and of country of residence on rates of admission to nursing homes and mortality. [2009.09]
Donepezil improves episodic memory in young individuals vulnerable to the effects of sleep deprivation. [2009.08.01]
The efficacy, safety, and tolerability of donepezil for the treatment of young adults with Down syndrome. [2009.08]
Donepezil improves episodic memory in young individuals vulnerable to the effects of sleep deprivation. [2009.08]
DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT. [2009.07.24]
Rates of Cognitive Change in Alzheimer Disease: Observations Across a Decade of Placebo-controlled Clinical Trials With Donepezil. [2009.06.25]
Donepezil delays progression to AD in MCI subjects with depressive symptoms. [2009.06.16]
Switching from donepezil tablets to rivastigmine transdermal patch in Alzheimer's disease. [2009.06]
Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial. [2009.05.05]
Ginkgo biloba extract EGb 761(R), donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: a randomised, double-blind, exploratory trial. [2009.03]
The changes of cortical metabolism associated with the clinical response to donepezil therapy in traumatic brain injury. [2009.03]
A rapid and specific approach for direct measurement of donepezil concentration in human plasma by LC-MS/MS employing solid-phase extraction. [2009.02]
Donepezil treatment of patients with MCI. A 48-week randomized, placebo-controlled trial. [2009.01.28]
Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan. [2009]
Effectiveness of donepezil in reducing clinical worsening in patients with mild-to-moderate alzheimer's disease. [2009]
A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia. [2008.12.12]
Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI. [2008.09]
A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia. [2008.08.07]
Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study. [2008.07]
[Effect of memantine treatment on patients with moderate-to-severe Alzheimer's disease treated with donepezil] [2008.07]
Effects of donepezil on verbal memory after semantic processing in healthy older adults. [2008.06]
Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial. [2008.05]
Donepezil improves obstructive sleep apnea in Alzheimer disease: a double-blind, placebo-controlled study. [2008.03]
The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics. [2008.03]
Effects of galantamine on measures of attention: results from 2 clinical trials in Alzheimer disease patients with comparisons to donepezil. [2008.01]
Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: results from a 24-week, double-blind, placebo-controlled, randomized trial. [2008]
Treatment of a whole population sample of Alzheimer's disease with donepezil over a 4-year period: lessons learned. [2008]
Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis. [2008]
Defining treatment response to donepezil in Alzheimer's disease: responder analysis of patient-level data from randomized, placebo-controlled studies. [2008]
The use of truncated area under the curves in the bioequivalence evaluation of long half-life drugs. Studies with donepezil and memantine. [2008]
Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study. [2007.12.19]
A double-blind, placebo-controlled trial of donepezil for the treatment of menopause-related cognitive loss. [2007.12]
Donepezil for the treatment of agitation in Alzheimer's disease. [2007.10.04]
[Clinical study of combined treatment with compound Reinhartdt and Sea Cumber Capsule and donepezil for vascular dementia] [2007.10]
No effect of donepezil on neurocognition and social cognition in young persons with stable schizophrenia. [2007.09]
No effect of donepezil on neurocognition and social cognition in young persons with stable schizophrenia. [2007.09]
Donepezil for cancer fatigue: a double-blind, randomized, placebo-controlled trial. [2007.08.10]
Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease. [2007.08]
Donepezil preserves cognition and global function in patients with severe Alzheimer disease. [2007.07.31]
Efficacy and Safety of Donepezil in Patients with Schizophrenia or Schizoaffective Disorder: Significant Placebo/Practice Effects in a 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. [2007.07.11]
A randomized, double-blind, placebo-controlled trial of donepezil to improve memory in epilepsy. [2007.07]
Does the cholinesterase inhibitor, donepezil, benefit both declarative and non-declarative processes in mild to moderate Alzheimer's disease? [2007.07]
Double-blind donepezil-placebo crossover augmentation study of atypical antipsychotics in chronic, stable schizophrenia: a pilot study. [2007.07]
A 12-week, double-blind, placebo-controlled trial of donepezil as an adjunct to haloperidol for treating cognitive impairments in patients with chronic schizophrenia. [2007.06]
A Randomized, Double-Blind, Placebo-Controlled Trial of Donepezil to Improve Memory in Epilepsy. [2007.05.01]
A randomized, double-blind, placebo-controlled trial of donepezil hydrochloride (Aricept) for reducing the incidence of postoperative delirium after elective total hip replacement. [2007.04]
Specific symptomatic changes following donepezil treatment of Alzheimer's disease: a multi-centre, primary care, open-label study. [2007.04]
Effects of donepezil adjunctive treatment to ziprasidone on cognitive deficits in schizophrenia: a double-blind, placebo-controlled study. [2007.01]
Effects of Donepezil Adjunctive Treatment to Ziprasidone on Cognitive Deficits in Schizophrenia: A Double-blind, Placebo-Controlled Study. [2007]
Atypical antipsychotics and pituitary neoplasms in the WHO database. [2007]
A randomized, placebo-controlled study of donepezil in poststroke aphasia. [2006.11.14]
The effect of donepezil on sleep in elderly, healthy persons: a double-blind placebo-controlled study. [2006.11]
Activities of daily living in moderate-to-severe Alzheimer disease: an analysis of the treatment effects of memantine in patients receiving stable donepezil treatment. [2006.10]
Cognitive response to memantine in moderate to severe Alzheimer disease patients already receiving donepezil: an exploratory reanalysis. [2006.10]
Safety and efficacy of donepezil in African Americans with mild-to-moderate Alzheimer's disease. [2006.10]
Donepezil effects on mood in patients with schizophrenia and schizoaffective disorder. [2006.10]
A randomized, double-blind, placebo-controlled trial of donepezil hydrochloride (Aricept) for reducing the incidence of postoperative delirium after elective total hip replacement. [2006.09.27]
Therapeutic and prophylactic utility of the memory-enhancing drug donepezil hydrochloride on cognition of patients undergoing electroconvulsive therapy: a randomized controlled trial. [2006.09]
Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study. [2006.09]
Donepezil for negative signs in elderly patients with schizophrenia: an add-on, double-blind, crossover, placebo-controlled study. [2006.09]
Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment. [2006.07.11]
Effects of donepezil on neuropsychiatric symptoms in patients with dementia and severe behavioral disorders. [2006.07]
Effects of donepezil on memory and cognition in multiple sclerosis. [2006.06.15]
Differential effects of the muscarinic M1 receptor agonist RS-86 and the acetylcholine-esterase inhibitor donepezil on REM sleep regulation in healthy volunteers. [2006.06]
A responder analysis of memantine treatment in patients with Alzheimer disease maintained on donepezil. [2006.05]
Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study. [2006.04.01]
[Clinical efficacy and safety of akatinol memantine in treatment of mild to moderate Alzheimer disease: a donepezil-controlled, randomized trial] [2006.04]
Efficacy and safety of donepezil in patients with dementia with Lewy bodies: preliminary findings from an open-label study. [2006.04]
Donepezil effects on cerebral blood flow in older adults with mild cognitive deficits. [2006.03]
Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease. [2006.03]
|